Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
8.25
-0.11 (-1.32%)
At close: Aug 26, 2026, 4:00 PM EDT
8.06
-0.19 (-2.30%)
After-hours: Aug 26, 2026, 4:19 PM EDT
Agenus Market Cap
Agenus has a market cap or net worth of $371.42 million as of August 26, 2026. Its market cap has increased by 165.49% in one year.
Market Cap
371.42M
Enterprise Value
393.39M
1-Year Change
165.49%
Ranking
Category
Stock Price
$8.25
ChartMarket Cap Chart
Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $371.42M, a decrease of -66.14%. That is a compound annual growth rate of -3.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 371.42M | 247.77% |
| Dec 31, 2025 | 106.80M | 66.10% |
| Dec 31, 2024 | 64.30M | -79.64% |
| Dec 29, 2023 | 315.80M | -56.83% |
| Dec 30, 2022 | 731.50M | -11.55% |
| Dec 31, 2021 | 827.00M | 36.76% |
| Dec 31, 2020 | 604.70M | 8.16% |
| Dec 31, 2019 | 559.10M | 95.76% |
| Dec 31, 2018 | 285.60M | -12.55% |
| Dec 29, 2017 | 326.60M | -9.03% |
| Dec 30, 2016 | 359.00M | -6.58% |
| Dec 31, 2015 | 384.30M | 54.40% |
| Dec 31, 2014 | 248.90M | 165.92% |
| Dec 31, 2013 | 93.60M | -7.14% |
| Dec 31, 2012 | 100.80M | 134.97% |
| Dec 30, 2011 | 42.90M | -57.23% |
| Dec 31, 2010 | 100.30M | 74.74% |
| Dec 31, 2009 | 57.40M | 80.50% |
| Dec 31, 2008 | 31.80M | -67.22% |
| Dec 31, 2007 | 97.00M | 15.61% |
| Dec 29, 2006 | 83.90M | -61.34% |
| Dec 30, 2005 | 217.00M | -52.90% |
| Dec 31, 2004 | 460.70M | 2.90% |
| Dec 31, 2003 | 447.70M | 32.18% |
| Dec 31, 2002 | 338.70M | -28.80% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 381.75M |
| Lyell Immunopharma | 380.56M |
| Clinuvel Pharmaceuticals | 376.65M |
| Century Therapeutics | 374.83M |
| Galectin Therapeutics | 371.13M |
| Palisade Bio | 365.97M |
| Capricor Therapeutics | 365.69M |
| Zentalis Pharmaceuticals | 362.12M |